Safety Reports: B. Braun Medical Inc, 824 12th Avenue, Bethlehem, Pennsylvania 18018, USA
Latest report:
Braun Medical Inc Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container - recalled due to Out-of-Specification Results
5 years ago •source fda.gov • details
Regulatory Report
Company name: Braun Medical Inc
Brand name: B. Braun
Product recalled: Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container
Reason of the recall: Out-of-Specification Results for High Molecular Weight Polymers
FDA Recall date: April 20, 2020
Recall details: Braun Medical…
Brand name: B. Braun
Product recalled: Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container
Reason of the recall: Out-of-Specification Results for High Molecular Weight Polymers
FDA Recall date: April 20, 2020
Recall details: Braun Medical…
1
Comments
Comment